April 9, 2025 - 18:43
The Stony Brook School of Health Professions hosted its 2025 Outstanding Alumni Awards ceremony on March 26, honoring a select group of distinguished alumni who have made significant contributions to the field of health professions. This prestigious event brought together faculty, current students, and alumni to recognize the achievements and dedication of those who have excelled in their respective careers.
During the ceremony, several alumni were acknowledged for their exceptional work and commitment to improving health care practices and patient outcomes. The awards not only highlight individual accomplishments but also serve to inspire current students to strive for excellence in their studies and future careers.
The event featured heartfelt speeches from award recipients, sharing their personal journeys and the impact their education at the School of Health Professions has had on their lives. The gathering fostered a sense of community and pride among attendees, reinforcing the school's mission to cultivate leaders in the health professions.
September 14, 2025 - 02:22
John Abraham Discusses Lake Health at Minnesota State FairJohn Abraham, a professor of mechanical engineering, recently appeared on WCCO Radio during the Minnesota State Fair, where he engaged in a conversation with hosts Adam Carter and Jordana Green....
September 13, 2025 - 01:39
Vaccine Advisory Committee to Review Covid Shot Data Next WeekThe vaccine advisory committee is set to convene next week to evaluate and make recommendations regarding the updated Covid shots for the upcoming fall season. This meeting comes at a time when...
September 12, 2025 - 02:37
Exploring the Future of Women's Health ResearchWhile we understand more about women’s health than ever before, critical gaps remain. How can we delve deeper into the lifestyle and genetic factors that influence women`s health outcomes? As we...
September 11, 2025 - 01:12
New FDA Regulations Target Compounded GLP-1 Medications While Apple Expands Health FeaturesThe FDA has announced new regulations aimed at addressing the rising popularity of compounded GLP-1 medications, which have gained traction as effective treatments for obesity and diabetes. These...